Top

Category: Pharma


Industry, Pharma

US frets over pharma supply chain security

June 22, 2022

Via: Pharmaphorum

In a global economy, across a number of industries, low-margin products are often manufactured in countries where labour is cheap. The pharmaceutical industry is no different, with India and China becoming two of the leading manufacturers and exporters of generic […]


Industry, Pharma

Bora Pharmaceuticals to Expand Operations

April 21, 2022

Via: Contract Pharma

Bora Pharmaceuticals, a fast-growing contract development and manufacturing organization (CDMO), is investing more than $10 million over the next 2 years to expand its oral solid dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario. The company’s CEO, Bobby […]


Industry, Pharma

FDA Revives Initiative to Identify and Reward Quality Drug Operations

April 12, 2022

Via: Biopharm International

To further encourage pharmaceutical companies to invest in the reliable production of higher quality products, FDA is reviving efforts to establish a Quality Management Maturity (QMM) program. An updated version of this approach is spelled out in a new White […]


FDA, Industry, Pharma, Regulations

FDA halts use of GlaxoSmithKline and Vir’s COVID-19 drug Xevudy in 8 northeast states

March 28, 2022

Via: FiercePharma

With new strains of the coronavirus showing their elusiveness and pushing more antibody treatments toward irrelevance, is there danger of an over-reliance on COVID-19 oral antivirals, especially Pfizer’s Paxlovid? Friday, the U.S. paused the distribution of GlaxoSmithKline and Vir Biotechnology’s […]


Industry, Pharma

Bayer plots $1.6B investment at German pharma manufacturing sites, with digital transformation a key component

March 3, 2022

Via: FiercePharma

If you think Bayer’s recent $180 million sale of a drug manufacturing facility in Germany means the company is scaling back on production in its home country, think again. Bayer plans to invest 1.4 billion euros ($1.55 billion) in its […]


Industry, Pharma

Anticancer Drug Promotes Weight Loss in Obese Mice

February 25, 2022

Via: Genetic Engineering and Biotechnology News

A study by researchers at Northwest A&F University in China has found that the anti-tumor drug, camptothecin (CPT) promotes weight loss in mice at low doses by activating a natural hunger-suppressing pathway. The study, headed by Jiang Wei Wu, PhD, […]


Industry, Pharma

Pharma’s digital inflection point

February 15, 2022

Via: Pharmaphorum

For Ford, the focus was on his company’s new range of consumer ‘biowearable’ health devices, but his appearance was also another reminder of the increasing importance of ‘digital’ in all its forms across the life sciences sector. Alongside buzzworthy metaverse, […]


Industry, Pharma

The pipeline of new antibiotics is drying up. A bill in Congress aims to change that.

February 1, 2022

Via: Biopharma Dive

Bacteria that can defeat current antibiotic drugs are sometimes called “the next pandemic.” Already, infections from them are believed to cause or contribute to more deaths worldwide than HIV/AIDS and malaria combined. Yet the pharmaceutical industry has been slow to […]


Industry, Pharma

The Considered pharmaceutical marketing experiment

December 23, 2021

Via: Pharmaphorum

“There is some brilliant work that takes place by some incredibly intelligent agencies and individuals, but I know how formulaic we’ve become as an industry where next year’s tactics are probably very similar to this year’s tactics,” he says. “What […]


Industry, Pharma

Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders

November 29, 2021

Via: Pharmaphorum

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies. It will take place […]


Industry, Pharma

Gilead pays up to retain rights to Arcus cancer drugs

November 18, 2021

Via: Biopharma Dive

The initial deal between Gilead and Arcus gave the larger drugmaker rights to an experimental drug called zimberelimab, which attacks cancers using the same mechanism as Keytruda, along with an option to license the four projects covered by Thursday’s announcement. […]


Industry, Pharma

Cortexyme plans path forward for Alzheimer’s drug that failed study

November 12, 2021

Via: Biopharma Dive

Faced with the failure of a key clinical trial, a California-based biotech is pressing ahead with plans to test its experimental Alzheimer’s drug in another study, convinced that signs of benefit observed in some patients are proof its treatment works. […]